To evaluate the therapeutic effectiveness of nasiyam using Aathondai nasiya thylam in the management of Peenisam (Sinusitis)

Phase 2

Not yet recruiting

• Conditions: Chronic sinusitis, unspecified,

• Registration Number: CTRI/2025/04/085801
• Lead Sponsor: Dr R MEENA

Brief Summary

This study is an open labelled non-randomized phase II clinical trial to evaluate the therapeutic effectiveness of

NASIYAM an external therapy using AATHONDAI NASIYA THYLAM in the management of PEENISAM.The trial drug will be an nasal application for daily for 21days in 40 patients.The trial period of 24 months will be

carried out in Government siddha medical College and hospital, Palayamkottai, Tirunelveli 627002,

Tamilnadu.The outcome will be an external therapy Nasiyam towards the management of Peenisam, expect the patients to be relieved from the symptom.In case of any adverse events (AE) is noticed and it will be referred to pharmacovigilence department for further management .The patients will be managed  as OPD patients.

Detailed Description

Not available

Study Timeline

• Last Update Posted: 2025-04-28
• Study Start: 2025-10-05

Recruitment & Eligibility

• Status: Not Yet Recruiting
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

Patients suffering from symptoms like nasal congestion, continuous sneezing ,headache or heaviness of head,pain in the face and ear,nasal or postnasal discharge, hyposmia Patients who are willing to give radiological investigation and provide blood for lab investigation Patients who are willing to sign the informed consent stating that he/she will stick to the treatment during the study period but can option out of the trail on his/her own conscious discretion.

Exclusion Criteria

Age below 15 years and above 70 years Patients suffering from epistaxis, lower respiratory tract infections, CAD, Tuberculosis,HIV,Cancer pregnant and lactating women, Epilepsy,CSF Rhinorrhoea, Haemophilia.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Patients symptoms will be reduced along with their improvement in their quality of life	21 days

Trial Locations

Locations (1)

Government Siddha Medical College and hospital; 🇮🇳 Tirunelveli, TAMIL NADU, India

Government Siddha Medical College and hospital

🇮🇳Tirunelveli, TAMIL NADU, India

Dr R MEENA

Principal investigator

8903784108

dr.meenarajamani98@gmail.com